Adora Ndu - 12 Oct 2022 Form 3 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Director
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Issuer symbol
ACAD
Transactions as of
12 Oct 2022
Net transactions value
$0
Form type
3
Filing time
14 Oct 2022, 18:53:32 UTC
Previous filing
11 Jun 2021
Next filing
05 Jun 2023

No securities are beneficially owned.